Twist Bioscience Corp. (TWST)
139.92
+4.45
(+3.28%)
USD |
NASDAQ |
Oct 23, 16:00
138.96
-0.96
(-0.69%)
After-Hours: 20:00
Twist Bioscience Market Cap : 8.769B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 8.769B |
| October 22, 2026 | 8.490B |
| October 21, 2026 | 9.347B |
| October 20, 2026 | 8.944B |
| October 19, 2026 | 8.760B |
| October 16, 2026 | 8.320B |
| October 15, 2026 | 9.056B |
| October 14, 2026 | 9.286B |
| October 13, 2026 | 9.484B |
| October 12, 2026 | 9.518B |
| October 09, 2026 | 10.01B |
| October 08, 2026 | 9.530B |
| October 07, 2026 | 9.755B |
| October 06, 2026 | 10.46B |
| October 05, 2026 | 12.85B |
| October 02, 2026 | 11.82B |
| October 01, 2026 | 11.79B |
| September 30, 2026 | 12.11B |
| September 29, 2026 | 11.67B |
| September 28, 2026 | 11.26B |
| September 25, 2026 | 11.46B |
| September 24, 2026 | 11.53B |
| September 23, 2026 | 9.934B |
| September 22, 2026 | 10.32B |
| September 21, 2026 | 10.39B |
| Date | Value |
|---|---|
| September 18, 2026 | 10.47B |
| September 17, 2026 | 9.750B |
| September 16, 2026 | 8.967B |
| September 15, 2026 | 8.655B |
| September 14, 2026 | 8.445B |
| September 11, 2026 | 7.973B |
| September 10, 2026 | 7.950B |
| September 09, 2026 | 7.867B |
| September 08, 2026 | 8.026B |
| September 04, 2026 | 7.817B |
| September 03, 2026 | 8.067B |
| September 02, 2026 | 8.210B |
| September 01, 2026 | 8.277B |
| August 31, 2026 | 8.712B |
| August 28, 2026 | 8.861B |
| August 27, 2026 | 9.595B |
| August 26, 2026 | 9.405B |
| August 25, 2026 | 9.490B |
| August 24, 2026 | 8.824B |
| August 21, 2026 | 9.125B |
| August 20, 2026 | 8.544B |
| August 19, 2026 | 8.924B |
| August 18, 2026 | 7.276B |
| August 17, 2026 | 7.797B |
| August 14, 2026 | 7.431B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.570B |
| Beam Therapeutics, Inc. | 2.484B |
| 10X Genomics, Inc. | 9.322B |
| Prime Medicine, Inc. | 663.31M |
| Moderna, Inc. | 79.84B |
Market Cap Related Metrics
| PS Ratio | 19.90 |
| PEG Ratio | -1.183 |
| Price to Book Value | 19.67 |
| Price | 139.92 |
| Earnings Yield | -1.59% |
| PEGY Ratio | -1.183 |